Articles On Holista CollTech (ASX:HCT)

What you should know about the different types of trading halts Why trading halts can protect investors Which companies are currently under suspension   For the most part, trading on the ASX takes place without interruption throughout the...

Listed biotech Holista Colltech (ASX: HCT) has been slapped with a $1.8 million penalty for breaching its continuous disclosure obligations and making misleading claims regarding the sales of its broad-spectrum sanitiser product NatShield d...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Benchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small caps led by Webcentral    The benchmark has ended another tortuous week of trade with a little Friday victory. Down -2.2% for the week, all...

Benchmark ASX index closes short by -0.04% Materials sector tries but cannot offset everyone else  Small caps led by HAL, DTC   The ASX200 Index has closed slightly lower after jumping early (+0.3%) out the gates on Wednesday morning. The...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Benchmark ASX index finishes +1% higher ASX Sectors led by Utilities (+4.2%) and all ended higher on the day Funny bunch of small cap winners including MOB, CZR, NGL   The ASX200 doesn’t seem to mind a bit of war on Tuesday, rising very...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Morgans says companies on the ASX are propelling our appetite product for health and wellness products Bioxyne says Covid has shown our susceptibility to disease, but also how resilient and strong we are in fighting it Anagenics says it’s...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

The weight loss drug frenzy is taking the world by storm Ozempic and Wegovy take drugmaker Novo Nordis to new highs Stockhead reached out to Holista’s CEO, Dato Dr. Rajendran Marnickacvasagar   The recent frenzy over Ozempic and Wegovy h...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

ASX chopped about sideways, losing any slight semblance of  fizz at close: -0.063% IT, Discretionary and Industrials led sectors, while Materials lagged The day’s clear winner was Mantle Minerals, up 50% at day’s end on further exploration...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

S&P/ASX 200 closes up 0.6%, while the emerging companies index rises 0.86% Austral’s US subsidiary Austral USA awarded a contract worth up to US$3.195 billion from the US Navy Pushpay ceases trading on the ASX and NZX following its $1....

S&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining regulator issues a mining permit for Terramin’s Tala Hamza zinc-lead project Retail component of Next DC’s entitlement offer opens and is expec...

After a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands on Australia’s biggest goldie takeover Westar Resources shines bright with a 47% price hike   As far as days on the ASX go, that definitely...

An afternoon rally has put some lead back in the market’s pencil, closing down 0.08%. Tech stocks and Small Ordinaries drive the wins, with InfoTech up 1.5% for the day. Lithium’s back on the menu, with three big names making some chunky,...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

ASX waddled to a -0.3% close, like a toddler with a turd in its trousers. Even the goldies retreated, with the XGD ASX All Ords Gold index dropping 0.20%. Blackmores sale is the most exciting thing to happen all day… which says it all, rea...

The ASX 200 was up 0.23% while the ASX XEC managed a 0.092% gain 8 out of 11 sectors were higher with Materials leading the way  The Real Estate sector was the weakest, down 0.77%   The ASX 200 was up 0.23% today while the ASX XEC squeez...

ASX 200 sinks to -2.2% before recovering to close near -1.5% for the day Energy sector tanks -5.0% because it wants to watch you cry in the shower Low unemployment data sets up the RBA to keep twisting Australia’s nipples, just the way we...

ASX hammered as bank-driven fear grips the market like a python round a possum XEC Emerging Companies falls more than 2.0% because they’re young and don’t know any better Safe haven goldies still managed to make bank. Sorry… poor choice of...

ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0%   Looking a...

The ASX fell 0.4% after Wall Street was hit by a massive sell-off overnight Wage data shows ‘real wage’ decline in 2022 is the worst in recorded history Toys’R’Us wins the day by offering to buy back its own beleaguered shares   And that’...

ASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of “weather balloon” debris met with hearty Pentagon chuckles Terramin’s bid to reopen a sub-winery mine shut down by the SA government   It’...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Audiences outraged over the benchmark’s “lacklustre, mediocre performance” today Standout winner Riedel Resources ends the day up by 50% on awesome assays FTX team drowning in irony as ‘hackers’ make off with more than $500 million   The...

Adelong Gold cranks out a 143% gain for the day ASX 200 benchmark feel by 0.13% by the close of play China’s December Quarter GDP figures are… let’s just say ‘questionably good at best’   We’ve just got time for a super-quick, lightning-...

Good news is bad news for the US economy Aussie benchmark goes deep into a pre-Christmas shame spiral Ho ho oh s%#$! What just happened?   The Closing Jingle Bell has rung, so that’s it until after Christmas for 2022! What a pity today’s...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Small caps up 0.86% while global markets wait for US midterm election results  Aussies have hit a record 1 million side hustles as the cost of living rises ReNu Energy nabs $100m investment from superannuation fund for green hydrogen proj...

Highlights Holista Colltech specialises in health and wellness solutions developed using a blend of the best of nature and science. Today, Holista has emerged as a strong player in the US$4.4 trillion global health and wellness industr...

ShareCafeWebinar Recap – TD1, MYL, C1X & HCT Catch up on the full webinar presentations from TALi (ASX: TD1), Mallee Resources (ASX: MYL), Cosmos Exploration (ASX: C1X) & Holista Colltech (ASX: HCT) Webinar Recap – TD1, MYL, C1X &a...

ShareCafeHolista Colltech (ASX: HCT) – Webinar Presentation Dr Rajen Manicka – Chairman and CEO – Holista is dedicated to delivering first-class natural ingredients and wellness products, and leads in research on herbs and food ingredients...

The ASX 200 is pretty flat, small caps up circa 0.5%  Materials and energy dragging locally Alibaba reports tonight: analysts predicting 30 thieves, down from previous high of 40   Around lunchtime, the major banks started passing on the...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging markets index closes 2.3% lower ASX200 pretty flat, maybe ahead by 0.1% March Qtr GDP rises 0.8%   The Emerging Companies Index has got a lithium leak. We don’t where, we don’t know why. It was down more than 2.7% and has kinda...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Emerging markets index up 0.5% ASX200 1% lower Belararox (ASX:BRX) rocks    The ASX Emerging Companies (XEC) Index was trading 0.6% higher after lunch to the exact degree the ASX200 (XJO) was not, 0.6% weaker. At the close the small cap...

XEC rises like a stubborn mule, up 0.5% XJO wobbles, equivocates somehow ends 0.2% higher Galileo Mining (ASX:GAL) gains circa 200%   Choppy trade – oh yes – but with Galileo Mining (ASX:GAL) coming out swinging on Wednesday morning, tha...

Central Banks have their fingers on the fun button this week, and the markets are pricing in the big push. The Emerging Companies Index (XEC) has been sunk on day dot, down 2.3%. The S&P/ASX 200 index was down 1.2% at 4.15pm, with this...